The Role of Inflammation in Ocular Tumours

Eligibility Details: Inclusion Criteria: Any tentative clinical diagnosis of: 1. Choroidal nevus (low-risk features): 2. Choroidal indeterminate melanocytic lesion (high-risk features) 3. Choroidal melanoma 4. Suspected metastatic tumour (ie, primary tumour elsewhere) 5. Locally treated ocular tumours Note that a patient can enroll in this study twice, once before treatment and once after, provided that at least one month has passed since initiation of treatment. This patient will count twice (ie, once in each of two study arms) Male and female age 18 years and older Ability to provide informed consent Exclusion Criteria: - Allergy to angiography dye - Cases that do not meet the above criteria for tumor size will be ineligible to participate in the study. - Patients not able to provide consent for the study. - Patients with a poor view of the fundus due to cataract or vitreous hemorrhage. - Patients < 18 years of age. Any concurrent unrelated eye diagnosis